Home
The Best-in-Class Fully Human Antibody Mouse.
in situ V(D)J substitution Fully Human Variable Domain Murine Constant Region![](https://renmab.com/wp-content/themes/renmab/img/bcell_1288.png)
![](https://renmab.com/wp-content/themes/renmab/img/bcell_840.png)
![](https://renmab.com/wp-content/themes/renmab/img/Antibody-1.png)
![](https://renmab.com/wp-content/themes/renmab/img/Antibody-2.png)
![](https://renmab.com/wp-content/themes/renmab/img/Antibody-3.png)
![](https://renmab.com/wp-content/themes/renmab/img/Antibody-4.png)
![](https://renmab.com/wp-content/themes/renmab/img/Antibody-5.png)
![](https://renmab.com/wp-content/themes/renmab/img/Antibody-6.png)
![](https://renmab.com/wp-content/themes/renmab/img/Antibody-7.png)
![](https://renmab.com/wp-content/themes/renmab/img/Antibody-8.png)
RenMab™
Best-in-class fully human antibody discovery platform
![](https://biocytogenstag.wpengine.com/wp-content/uploads/mice-renmab.png)
Fully human heavy chain and kappa
light chain V(D)J loci substitution
![](https://renmab.com/wp-content/uploads/biocyto_hitsplatform_lightbg_v01.png)
RenMice® HiTS Platform
The RenMice® HiTS (Hyperimmune Target Specific) Platform consists of a library of RenMice® each with a specific target gene knocked out. These mice are designed to elicit robust immune responses against homologous proteins and generate antibodies that bind to broader epitopes.
Learn MoreBIOCYTOGEN & RENMAB COMMERCIAL BENEFITS
![](https://renmab.com/wp-content/uploads/licensing-icon.png)
Licensing Options
License directly with Biocytogen
Option to use through other CROs or in-house
![](https://renmab.com/wp-content/uploads/codev-icon.png)
Co-development Opportunities
Exclusive partnership opportunities using our RenMice® HiTS Platform
![](https://renmab.com/wp-content/uploads/flexibility-icon.png)
Flexibility
Flexible terms tailored to accommodate different antibody programs